Patents by Inventor Daniel BINZEL

Daniel BINZEL has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TARGETED DELIVERY OF DRUG MOLECULES WITH DRUG LIGANDS CONJUGATED TO RNA NANOPARTICLE MOTION ELEMENTS
    Publication number: 20240165241
    Abstract: Disclosed herein is a therapeutics structure containing a motion element, an methotrexate (MTX), N—[N—[(S)-1,3-dicarboxypropyl]carbamoyl]-(S)-lysine (DCL), or UAMC-1110 ligand, and a plurality of drugs selected from the group consisting of camptothecin (CPT), paclitaxel (PTX), podophyllotoxin (PTOX), 7-Ethyl-10-hydroxycamptothecin (SN38), BMS1, BMS8, BMS27, BMS242, LY294002, PI3K-IN-20, and methotrexate (MTX).
    Type: Application
    Filed: February 17, 2023
    Publication date: May 23, 2024
    Inventors: Peixuan GUO, Daniel BINZEL, Peter BLANCO CARCACHE, Xin LI, Congcong XU